Western Daily Press (Saturday)
WHO backs AZ jabs as safe to use
COUNTRIES should continue to use the AstraZeneca Covid-19 vaccine, the World Health Organisation (WHO) said, saying there was no indication of a link between the jabs and blood clots.
It comes after Thailand said it will delay use of the AstraZeneca vaccine after several European countries temporarily suspended the jabs following a small number of reports of health problems. Speaking via videoconference in Geneva, WHO director general Tedros Adhanom Ghebreyesus said: “As countries roll out Covid-19 vaccines, WHO is continuing to keep a close eye on their safety.
“WHO is aware that some countries have suspended the use of AstraZeneca vaccines based on reports of blood clots in some people who have received doses of the vaccine from two batches.
“This measure was taken as a precaution while a full investigation is finalised. It’s important to note that the European Medicines Agency has said there is no indication of a link between the vaccine and blood clots and that the vaccine can continue to be used while its investigation is ongoing.”
He said the findings and any change to the organisation’s recommendations following the investigation will be relayed to the public “immediately”.
His comments echoed earlier remarks made by WHO spokesperson Dr Margaret Harris, who described the vaccine as “excellent”. Yong Poovorawan, an adviser to Thailand’s vaccination programme, said the delay, pending an investigation into the cause of reported side effects, will not have a big impact on the rollout.
It came as AstraZeneca released a new statement saying there is no evidence of an increased risk of pulmonary embolism or deep vein thrombosis with the vaccine. It said that, in fact, the occurrence is “significantly lower” in those who have been vaccinated than what would be expected among the general population.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has said there is no evidence to suggest the vaccine causes blood clot problems, and that people should still get their Covid-19 jab when asked to do so.
The European Medicines Agency (EMA) has also backed the jab’s safety and said there have been 30 reports of blood clots among close to five million people given the vaccine across Europe.
On Thursday, Denmark, Norway and Iceland said they were temporarily halting all AstraZeneca vaccinations to investigate reports of blood clots among people who have had the jab.
Italy also followed Austria, Estonia, Latvia, Luxembourg and Lithuania in banning jabs from one particular batch of one million AstraZeneca vaccines, which was sent to 17 countries, after reports of a death.